What can we learn from a metagenomic analysis of a georgian bacteriophage cocktail?

Viruses

Volumn 7, Issue 12, 2015, Pages 6570-6589

  Zschach, Henrike ^a   Joensen, Katrine G ^a   Lindhard, Barbara ^a   Lund, Ole ^a   Goderdzishvili, Marina ^b   Chkonia, Irina ^b   Jgenti, Guliko ^b   Kvatadze, Nino ^b   Alavidze, Zemphira ^c   Kutter, Elizabeth M ^d   Hasman, Henrik ^a   Larsen, Mette V ^a  

^a TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^b Laboratory of Genetic Engineering and Biotechnology   (United States)

^c Eliava Biopreparations LTD   (United States)

^d EVERGREEN STATE COLLEGE   (United States)

Author keywords

Eliava Intestiphage; J0101; Metagenomics; PACS; Phage therapy; Whole genome sequence analysis

Indexed keywords

BACTERIAL STRAIN; BACTERIOPHAGE; BIOINFORMATICS; CLINICAL ARTICLE; DATA BASE; LYSIS; METAGENOMICS; PROTEUS; T4LIKEVIRUS; T5LIKEVIRUS; T7LIKEVIRUS; CLASSIFICATION; ENTEROBACTERIACEAE; GENETICS; GEORGIA; METAGENOME; MYOVIRIDAE; PODOVIRIDAE; SIPHOVIRIDAE; STANDARDS; VIROLOGY; VIRUS GENOME;

BIOLOGICAL PRODUCT;

BACTERIOPHAGES; BIOLOGICAL PRODUCTS; ENTEROBACTERIACEAE; GENOME, VIRAL; GEORGIA; METAGENOME; METAGENOMICS; MYOVIRIDAE; PODOVIRIDAE; SIPHOVIRIDAE;

EID: 84949933870     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v7122958     Document Type: Article

References (43)

1. World Health Organization. Antimicrobial Resistance Global Report on Surveillance 2014; World Health Organization: Geneva, Switzerland, 2014.
2. Lu, T.K.; Koeris, M.S. The next generation of bacteriophage therapy. Curr. Opin. Microbiol. 2011, 14, 524–531. [CrossRef][PubMed]
3. Chan, B.K.; Abedon, S.T.; Loc-Carrillo, C. Phage cocktails and the future of phage therapy. Future Microbiol. 2013, 8, 769–783. [CrossRef][PubMed]
4. Hatfull, G.F. Bacteriophage genomics. Curr. Opin. Microbiol. 2008, 11, 447–453. [CrossRef][PubMed]
5. Reardon, S. Phage therapy gets revitalized. Nature 2014, 510, 15–16. [CrossRef][PubMed]
6. Harper, D.R.; Anderson, J.; Enright, M.C. Phage therapy: Delivering on the promise. Ther. Deliv. 2011, 2, 935–947. [CrossRef][PubMed]
7. Kutateladze, M.; Adamia, R. Bacteriophages as potential new therapeutics to replace or supplement antibiotics. Trends Biotechnol. 2010, 28, 591–595. [CrossRef][PubMed]
8. Kutter, E.; Borysowski, J.; Międzybrodzki, R.; Górski, A.; Weber-Da˛browska, B.; Kutateladze, M. Clinical phage therapy. In Phage Therapy: Current Research and Applications, 1st ed.; Borysowski, J., Międzybrodzki, R., Górski, A., Eds.; Caister Academic Press: Poole, UK, 2014; pp. 253–284.
9. Kutter, E.; de Vos, D.; Gvasalia, G.; Alavidze, Z.; Gogokhia, L.; Kuhl, S.; Abedon, S.T. Phage therapy in clinical practice: Treatment of human infections. Curr. Pharm. Biotechnol. 2010, 11, 69–86. [CrossRef][PubMed]
10. Abedon, S.T.; Kuhl, S.J.; Blasdel, B.G.; Kutter, E.M. Phage treatment of human infections. Bacteriophage 2011, 1, 66–85. [CrossRef][PubMed]
11. Sulakvelidze, A.; Alavidze, Z.; Morris, J.G. Bacteriophage therapy. Antimicrob. Agents Chemother. 2011, 45, 649–659. [CrossRef][PubMed]
12. Bruttin, A.; Brüssow, H. Human volunteers receiving Escherichia coli phage T4 orally: A safety test of phage therapy. Antimicrob. Agents Chemother. 2005, 49, 2874–2878. [CrossRef][PubMed]
13. Sarker, S.A.; McCallin, S.; Barretto, C.; Berger, B.; Pittet, A.-C.; Sultana, S.; Krause, L.; Huq, S.; Bibiloni, R.; Bruttin, A., et al. Oral T4-like phage cocktail application to healthy adult volunteers from Bangladesh. Virology 2012, 434, 222–232. [CrossRef][PubMed]
14. Wright, A.; Hawkins, C.H.; Anggård, E.E.; Harper, D.R. A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa; a preliminary report of efficacy. Clin. Otolaryngol. 2009, 34, 349–357. [CrossRef][PubMed]
15. Rhoads, D.D.; Wolcott, R.D.; Kuskowski, M.A.; Wolcott, B.M.; Ward, L.S.; Sulakvelidze, A. Bacteriophage therapy of venous leg ulcers in humans: Results of a phase I safety trial. J. Wound Care 2009, 18, 237–243. [CrossRef][PubMed]
16. McCallin, S.; Sarker, S.A.; Barretto, C.; Sultana, S.; Berger, B.; Huq, S.; Krause, L.; Bibiloni, R.; Schmitt, B.; Reuteler, G., et al. Safety analysis of a Russian phage cocktail: From metagenomic analysis to oral application in healthy human subjects. Virology 2013, 443, 187–196. [CrossRef][PubMed]
17. Brüssow, H. What is needed for phage therapy to become a reality inWestern medicine? Virology 2012, 434, 138–142. [CrossRef][PubMed]
18. Breitbart, M.; Salamon, P.; Andresen, B.; Mahaffy, J.M.; Segall, A.M.; Mead, D.; Azam, F.; Rohwer, F. Genomic analysis of uncultured marine viral communities. Proc. Natl. Acad. Sci. USA 2002, 99, 14250–14255. [CrossRef][PubMed]
19. D’Herelle, F. The Bacteriophage; Williams & Wilkins Company: Baltimore, MD, USA, 1922.
20. Mikeladze, C.; Nemsadze, E.; Alexidze, N.; Assanichvili, T. Sur le traitement de la fievre typhoide et des colites aigues par le bacteriophage de d'Herelle. La Médecine 1936, 17, 33–38. (In French).
21. Chanishvili, N. A Literature Review of the Practical Application of Bacteriophage Research; Nova Science Publishers: New York, NY, USA, 2012.
22. Kuhl, S.J.; Mazure, H. d’Hérelle. Preparation of Therapeutic Bacteriophages, Appendix 1 from: Le Phénomène de la Guérison dans les maladies infectieuses: Masson et Cie, 1938, Paris—OCLC 5784382. Bacteriophage 2011, 1, 55–65. [CrossRef]
23. Andrews, S. FastQC—A Quality Control Tool for High Throughput Sequence Data. Available online: http://www.bioinformatics.bbsrc.ac.uk/projects/fastqc/ (accessed on 1 February 2015).
24. Schmieder, R.; Edwards, R. Quality control and preprocessing of metagenomic datasets. Bioinformatics 2011, 27, 863–864. [CrossRef][PubMed]
25. Laserson, J.; Jojic, V.; Koller, D. Genovo: De novo assembly for metagenomes. J. Comput. Biol. 2011, 18, 429–443. [CrossRef][PubMed]
26. Zerbino, D.R.; Birney, E. Velvet: Algorithms for de novo short read assembly using de Bruijn graphs. Genome Res. 2008, 18, 821–829. [CrossRef][PubMed]
27. Altschul, S.F.; Gish, W.; Miller, W.; Myers, E.W.; Lipman, D.J. Basic local alignment search tool. J. Mol. Biol. 1990, 215, 403–410. [CrossRef]
28. Deurenberg, R.H.; Stobberingh, E.E. The evolution of Staphylococcus aureus. Infect. Genet. Evol. 2008, 8, 747–763. [CrossRef][PubMed]
29. Li, H.; Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 2009, 25, 1754–1760. [CrossRef][PubMed]
30. Aziz, R.K.; Bartels, D.; Best, A.A.; DeJongh, M.; Disz, T.; Edwards, R.A.; Formsma, K.; Gerdes, S.; Glass, E.M.; Kubal, M., et al. The RAST Server: Rapid annotations using subsystems technology. BMC Genom. 2008, 9. [CrossRef][PubMed]
31. Besemer, J. GeneMarkS: A self-training method for prediction of gene starts in microbial genomes. Implications for finding sequence motifs in regulatory regions. Nucleic Acids Res. 2001, 29, 2607–2618. [CrossRef][PubMed]
32. Lobocka, M.; Hejnowicz, M.S.; Gagala, U.; Weber-Dąbrowska, B.; Wegrzyn, G.; Dadlez, M. The first step to bacteriophage therapy: How to choose the correct phage. In Phage Therapy: Current Research and Applications; Borysowski, J., Międzybrodzki, R., Gorski, A., Eds.; Caister Academic Press: Norfolk, UK, 2014; pp. 23–67.
33. Samson, J.E.; Magadán, A.H.; Sabri, M.; Moineau, S. Revenge of the phages: Defeating bacterial defences. Nat. Rev. Microbiol. 2013, 11, 675–687. [CrossRef][PubMed]
34. Zankari, E.; Hasman, H.; Cosentino, S.; Vestergaard, M.; Rasmussen, S.; Lund, O.; Aarestrup, F.M.; Larsen, M.V. Identification of acquired antimicrobial resistance genes. J. Antimicrob. Chemother. 2012, 67, 2640–2644. [CrossRef][PubMed]
35. Joensen, K.G.; Scheutz, F.; Lund, O.; Hasman, H.; Kaas, R.S.; Nielsen, E.M.; Aarestrup, F.M. Real-time whole-genome sequencing for routine typing, surveillance, and outbreak detection of verotoxigenic Escherichia coli. J. Clin. Microbiol. 2014, 52, 1501–1510. [CrossRef][PubMed]
36. Santos, S.B.; Kropinski, A.M.; Ceyssens, P.-J.; Ackermann, H.-W.; Villegas, A.; Lavigne, R.; Krylov, V.N.; Carvalho, C.M.; Ferreira, E.C.; Azeredo, J. Genomic and proteomic characterization of the broad-host-range Salmonella phage PVP-SE1: Creation of a new phage genus. J. Virol. 2011, 85, 11265–11273. [CrossRef][PubMed]
37. Schwarzer, D.; Buettner, F.F.R.; Browning, C.; Nazarov, S.; Rabsch, W.; Bethe, A.; Oberbeck, A.; Bowman, V.D.; Stummeyer, K.; Mühlenhoff, M., et al. A multivalent adsorption apparatus explains the broad host range of phage phi92: A comprehensive genomic and structural analysis. J. Virol. 2012, 86, 10384–10398. [CrossRef][PubMed]
38. Zuo, G.; Xu, Z.; Hao, B. Shigella strains are not clones of Escherichia coli but sister species in the genus Escherichia. Genom. Proteom. Bioinform. 2013, 11, 61–65. [CrossRef][PubMed]
39. Sheldon, A.T. Antiseptic “resistance”: Real or perceived threat? Clin. Infect. Dis. 2005, 40, 1650–1656. [CrossRef][PubMed]
40. Piechowski, M.M.; Susman, M. Acridine-resistance in phage T4D. Genetics 1967, 56, 133–148. [PubMed]
41. Kawai, M.; Yamada, S.; Ishidoshiro, A.; Oyamada, Y.; Ito, H.; Yamagishi, J.-I. Cell-wall thickness: Possible mechanism of acriflavine resistance in meticillin-resistant Staphylococcus aureus. J. Med. Microbiol. 2009, 58, 331–336. [CrossRef][PubMed]
42. Wang, F.J.; Ripley, L.S. The spectrum of acridine resistant mutants of bacteriophage T4 reveals cryptic effects of the tsL141DNApolymerase allele on spontaneous mutagenesis. Genetics 1998, 148, 1655–1665. [PubMed]
43. Deghorain, M.; van Melderen, L. The Staphylococci phages family: An overview. Viruses 2012, 4, 3316–3335. [CrossRef][PubMed]